Qx Medical
QXMédical is a privately held medical device company that designs and manufactures proprietary balloon and delivery catheter devices for minimally invasive coronary, peripheral, and endovascular interventions, serving interventional cardiologists, vascular surgeons, interventional radiologists, and emergency/trauma care providers through channel partners and direct sales.
- Company typePrivate
- Founded2007
- HeadquartersMontréal, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Qx Medical does
QXMédical is a privately held medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. Founded in 2007 in Montreal, Canada, the company relocated primary operations to Saint Paul, Minnesota in 2010 and operates from a corporate headquarters and integrated Technology & Manufacturing Center at 2820 Patton Road. Its product portfolio is anchored by two proprietary technology platforms: a balloon technology platform driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, and PTA/PTCA; and a catheter technology platform powering delivery, procedural support, and crossing catheters. Commercialized products include the Q50 PLUS and Q50X stent graft balloon catheters for AAA/TAA, the EVAR Balloon Catheter (over 100,000 clinical cases), the Occlusion Balloon Catheter for trauma and hemorrhage control, and the Boosting Catheter guide extension catheter (over 50,000 clinical uses worldwide). The pipeline also includes i-FLEX bioresorbable embolization particles, developed and commercialized through subsidiary BiologiQ.
The company monetizes primarily through hardware sales of prescription medical devices to healthcare providers and through licensing/royalty arrangements tied to its BiologiQ subsidiary (worldwide exclusive rights to bioresorbable embolic technology licensed from the University of Minnesota in 2019). Distribution is hybrid: a Strategic Partner Program with companies of all sizes including some of the largest U.S. medical device companies, supplemented by direct sales and regional distributors. End customers are interventional cardiologists, interventional radiologists, vascular surgeons, and emergency/trauma care providers in North America and Europe. The company is ISO 13485:2016 certified, holds multiple FDA 510(k) clearances, and achieved EU MDR certification for the Boosting Catheter in July 2024. A definitive settlement with Teleflex in October 2025 cleared patent litigation, enabling U.S. market launch of the Boosting Catheter in 2026.
Qx Medical firmographics
Firmographics- Name
- Qx Medical
- Legal name
- QXMédical, LLC
- Website
- https://qxmedical.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- QXMédical is a privately held medical device company that designs and manufactures proprietary balloon and delivery catheter devices for minimally invasive coronary, peripheral, and endovascular interventions, serving interventional cardiologists, vascular surgeons, interventional radiologists, and emergency/trauma care providers through channel partners and direct sales.
- Ownership category
- akta.pro rank
Qx Medical industry classification
Industry- Product category
- Vascular Intervention Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE)
- akta.pro secondary industry
- Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
Keywords
Where Qx Medical is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices4 records
Markets served
Qx Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of proprietary balloon catheters, guide extension catheters, and embolic agents to healthcare providers and medical facilities
- Licensed Technology Commercialization: Commercialization of bioresorbable embolic technology licensed from University of Minnesota through subsidiary BiologiQ
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Qx Medical product offering
Product offeringCore offering
Qx Medical designs and manufactures first-in-class medical devices for minimally invasive coronary, peripheral, and endovascular interventions. The product portfolio centers on proprietary balloon catheters and delivery catheters for vessel occlusion, stent graft expansion, and procedural support, alongside bioresorbable embolization particles developed through subsidiary BiologiQ.
Product overview
QXMédical is a medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. The company's core technology platforms center on proprietary balloon technology (driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, PTA/PTCA) and catheter technology (for delivery catheters, procedural support devices, crossing catheters). The product portfolio includes: stent graft balloon catheters (Q50 PLUS, Q50X), guide extension catheters (Boosting Catheter), embolization particles (i-FLEX), EVAR Balloon Catheters, and Occlusion Balloon Catheters. Products serve endovascular interventions, coronary and peripheral vascular interventions, and emergency/trauma care applications.
Differentiator
Problem solved
Functional benefit
Brands
- BiologiQ: Subsidiary of QXMédical managing bioresorbable embolic technology development, regulatory submissions and commercialization.
Products and services
- Q50 PLUS Stent Graft Balloon Catheter
Quantifiable outcome
- Over 100,000 clinical cases using EVAR Balloon Catheter technology
- +2 more outcomes
Companies that use Qx Medical
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Qx Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Qx Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- University of MinnesotacoreQXMédical acquired worldwide exclusive rights to bioresorbable embolic technology developed by researchers and physicians at the University of Minnesota. This novel technology provides resorbable and drug-loadable microspheres and hydrogels for embolization procedures. The technology is managed through BiologiQ, a subsidiary of QXMédical, for final development, regulatory submissions and commercialization.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Qx Medical competitors and assessment
Company assessmentDirect peers
- Teleflex: Teleflex is a large U.S. medical device company that markets guide extension catheters and other interventional cardiology products. QXMédical's Boosting Catheter is a direct competitor to Teleflex's offering, as evidenced by the October 2025 patent settlement between the two companies.
- Terumo: Terumo is a global medical device company with a strong portfolio in interventional cardiology and peripheral vascular catheters, including guide extension and balloon products. QXMédical's Boosting Catheter and balloon catheter portfolio directly competes in the same cath lab and IR procedural categories as Terumo.
- Penumbra: Penumbra is a focused vascular intervention company with catheter-based technologies for thrombectomy, embolization and peripheral vascular procedures. QXMédical's embolization particle and occlusion balloon catheter products compete in overlapping endovascular and trauma embolization markets served by Penumbra.
- Inari Medical: Inari Medical develops catheter-based therapies for venous thromboembolism and peripheral vascular disease, with significant overlap in catheter engineering and endovascular treatment of complex vascular disease. QXMédical's balloon and delivery catheter platforms address similar interventional procedure use cases.
- Merit Medical Systems: Merit Medical is a manufacturer of disposable interventional devices including catheters, balloon inflation devices, and embolization products. QXMédical's balloon catheters and embolization particles are direct comparables to Merit's peripheral intervention and embolic therapy portfolio.
- AngioDynamics: AngioDynamics is a medical device company focused on vascular access, peripheral vascular disease, and oncology/embolization therapies. QXMédical's EVAR balloon catheters, occlusion balloons, and i-FLEX embolization particles compete in similar peripheral vascular and embolization procedure categories.
Broad incumbents
- Boston Scientific: Boston Scientific is a large incumbent in interventional cardiology and peripheral vascular intervention with broad catheter, guide extension, and embolic therapy portfolios (including the legacy BTG embolic franchise). QXMédical's coronary and peripheral catheter products compete in overlapping procedure categories with Boston Scientific's installed base.
- Medtronic: Medtronic is a global medical device leader with deep portfolios in interventional cardiology, peripheral vascular and endovascular therapies. QXMédical's catheter and balloon platforms for PCI, EVAR and embolization compete for the same physician customers and hospital budgets as Medtronic's broad cardiovascular franchise.
- Abbott Vascular: Abbott Vascular is a leading manufacturer of coronary and peripheral vascular intervention devices, including guide catheters, guide extension systems, and balloon technologies. QXMédical's guide extension and EVAR balloon catheter products address overlapping use cases in Abbott's core catheter lab markets.
Emerging players
- Surmodics: Surmodics is a smaller medical device company with a peripheral vascular intervention portfolio including drug-coated balloons and specialty catheter technologies. QXMédical's peripheral balloon and catheter products are comparable in scale and target use cases, making Surmodics a useful emerging peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Qx Medical social profiles
Digital presenceQx Medical compliance and trust
Trust signalCompliance1 record
Qx Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qx Medical leadership team
Management profileNumber of profiles
Profiles3 records
Qx Medical subsidiaries and ownership
Company hierarchySubsidiaries1 record
Qx Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qx Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qx Medical
What does Qx Medical do?
Qx Medical designs and manufactures first-in-class medical devices for minimally invasive coronary, peripheral, and endovascular interventions. The product portfolio centers on proprietary balloon catheters and delivery catheters for vessel occlusion, stent graft expansion, and procedural support, alongside bioresorbable embolization particles developed through subsidiary BiologiQ.
Is Qx Medical a public or private company?
Qx Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Qx Medical founded?
Qx Medical was founded in 2007. It employs 1 to 10 people.
Where is Qx Medical based?
Qx Medical is headquartered in Montréal, Canada, in the North America region.
How does Qx Medical make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are licensed Technology Commercialization.
Who are Qx Medical's main competitors?
Direct peers on record are Teleflex, Terumo, Penumbra, Inari Medical, Merit Medical Systems and AngioDynamics. Broad incumbents are Boston Scientific, Medtronic and Abbott Vascular. Surmodics is listed as an emerging player.
Does Qx Medical have an API?
No public API is recorded for Qx Medical.
What industry is Qx Medical in?
Qx Medical's product category is Vascular Intervention Devices. Its primary akta.pro industry code is HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy), with a secondary code of HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 339112 and its SIC code is 3841.